3.210EUR
127.00 MEUR
684.60 MEUR
565.87 K
About BIOTEST AG ST O.N.
Sector
CEO
Peter Janssen
Headquarters
Dreieich
Website
Employees (FY)
2.43 K
Founded
1946
ISIN
DE0005227201
FIGI
BBG000BL3BK0
Biotest AG engages in the development, manufacture, and marketing of plasma proteins and biotherapeutic drugs. It operates through the following segments: Therapy, Plasma and Services, and Other. The Therapy segment develops and produces blood plasma-based immunoglobulins, clotting factors, and albumins which are used to treat diseases of the immune system, haematological diseases, and in intensive care medicine. The Plasma and Services segment includes the areas of plasma sales and contract manufacturing. The Other segment refers to the merchandise business. The company was founded by Carl Adolf Schleussner and Hans Schleussner in 1946 and is headquartered in Dreieich, Germany.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BIO is 41.600 EUR — it has increased by 0.48% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HAM exchange BIOTEST AG ST O.N. stocks are traded under the ticker BIO.
BIOTEST AG ST O.N. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track BIOTEST AG ST O.N. financials in yearly and quarterly reports right on TradingView.
Like other stocks, BIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOTEST AG ST O.N. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 2.43 K employees. See our rating of the largest employees — is BIOTEST AG ST O.N. on this list?